Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03586661
Title Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

peritoneum cancer

fallopian tube cancer

endometrial adenocarcinoma

ovary serous adenocarcinoma


Copanlisib + Niraparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.